Last reviewed · How we verify
NCT04886102
Molecular Epidemiology of Hepatitis B in Cayenne General Hospital, French Guiana
trial testing An additional 5 mL venous blood tube taken from patients during their routine medical check-up at the hospital in Hepatitis B, Chronic in 400 participants. Status unknown.
1 February 2022
Quick facts
| Lead sponsor | Centre Hospitalier de Cayenne |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 400 |
| Start date | 11 February 2021 |
| Primary completion | 1 February 2022 |
| Estimated completion | 1 February 2022 |
| Sites | 1 location across French Guiana |
Drugs / interventions tested
- An additional 5 mL venous blood tube taken from patients during their routine medical check-up at the hospital
Conditions studied
- Hepatitis B, Chronic — all drugs for Hepatitis B, Chronic →
- Adults — all drugs for Adults →
Sponsor
Centre Hospitalier de Cayenne
Who can join
18 and older, any sex, with Hepatitis B, Chronic or Adults. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
In South America, the prevalence of HBV is variable but high (\> 8%) in the Amazon basin. In some areas, a third of HBsAg carriers are also infected with HDV, a major comorbidity factor. The pre-core mutations are associated with the negative HBe Ag phenotype which is associated with a more severe course. These mutations are of increasing and high frequency. French Guiana is populated by populations of African, European and Asian origins with chains of viral transmission which are not known and viruses probably of different origins with variable virulence and transmission potentials.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04886102
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Hepatitis B, Chronic
Currently open trials in the same condition.
- NCT07370207 — Phase 2 Study of AHB-137 in HBeAg Negative Chronic Hepatitis B (CHB) Participants in Asia Pacific Region · Phase 2 · recruiting
- NCT06550622 — Improved Sensitivity Detection of Serum HBsAg and HBsAg Reversion · recruiting
- NCT06550128 — Study to Evaluate the Efficacy and Safety of AHB-137 Injection in Participants With Chronic Hepatitis B (CHB). · Phase 2 · active not recruiting
- NCT06525909 — A Real-world Study of Staging and Grading of Clinical Immune Status in Chronic Hepatitis B · recruiting
- NCT05937178 — Real-world Study Optimizing Nucleotide-analogues · recruiting
Other Centre Hospitalier de Cayenne trials
Trials by the same sponsor.
- NCT06543875 — Overweight, Obesity and Weight Variation Among Incarcerated Women in French Guiana: a Study of Factors Associated With W · completed
- NCT06065553 — Prevalence of Psychiatric and Substance Abuse Disorders Among People in Precarious Situations in Cayenne · recruiting
- NCT06095076 — Cutaneous Microbiota Evolution in ICU Patients With CVC (ICMc) · unknown
- NCT05814068 — Active Screening of Arterial Hypertension by Community Outreach Workers in the Cayenne Metropolitan Area to Reduce the I · NA · unknown
- NCT06692985 — Epidemiology of Cutaneous Leishmaniasis in Niger, Mali, Togo : Mapping of Clinical Cases, Species, Reservoirs and Vector · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04886102 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Centre Hospitalier de Cayenne
- Last refreshed: 13 May 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04886102.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing